CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 3, May/June 2014
AFRICA
129
extremity ischemia: revised version.
J Vasc Surg
1997;
26
(3): 517–538.
6.
De Vries M, Ouwendijk R, Kessels AG, de Haan MW, Flobbe K,
Hunink MG,
et al.
Comparison of generic and disease-specific ques-
tionnaires for the assessment of quality of life in patients with periph-
eral arterial disease.
J Vasc Surg
2005;
41
: 261–268.
7.
Khaira HS, Hanger R, Shearman CP. Quality of life in patients with
intermittent claudication.
Eur J Vasc Endovasc Surg
1996;
11
: 65–69.
8.
Hicken GJ, Lossing AG, Ameli M. Assessment of generic health-related
quality of life in patients with intermittent claudication.
Eur J Vasc
Endovasc Surg
2000;
20
: 336–341.
9.
Pell JP. Impact of intermittent claudication on quality of life. The
Scottish Vascular Audit Group.
Eur J Vasc Endovasc Surg
1995;
9
:
469–472.
10. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D,
McDermott MM,
et al
. The impact of peripheral arterial disease on
health-related quality of life in the Peripheral arterial diseaseAwareness,
Risk, and Treatment: New Resources for Survival (PARTNERS)
Program.
Vasc Med
2008;
13
(1): 15–24.
11. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for
claudication: assessment of exercise performance, functional status,
and clinical end points. Vascular Clinical Trialists.
Circulation
1995;
92
: 614–621.
12. Bosch JL, van der Graaf Y, Hunink MG. Health-related quality of
life after angioplasty and stent placement in patients with iliac artery
occlusive disease: results of a randomized controlled clinical trial. The
Dutch Iliac Stent Trial Study Group.
Circulation
1999;
99
: 3155–3160.
13. Cassar K, Bachoo P, Brittenden J. The effect of peripheral percutaneous
transluminal angioplasty on quality of life in patients with intermittent
claudication.
Eur J Vasc Endovasc Surg
2003;
26
: 130–136.
14. Chetter IC, Spark JI, Kent PJ, Berridge DC, Scott DJ, Kester RC.
Percutaneous transluminal angioplasty for intermittent claudication:
evidence on which to base the medicine.
Eur J Vasc Endovasc Surg
1998;
16
: 477–484.
15. Dormandy JA, Rutherford RB. Management of peripheral arterial
disease (PAD). TASC Working Group. TransAtlantic Inter-Society
Concensus (TASC).
J Vasc Surg
2000;
31
: S1–S296.
16. Mehta T, Venkata Subramaniam A, Chetter I, McCollum P. Disease
specific quality of life assessment in intermittent claudication: review.
Eur J Vasc Endovasc Surg
2003;
25
: 202–208.
17. Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the Vascular
Quality of Life Questionnaire: a new disease-specific quality of life
measure for use in lower limb ischemia.
J Vasc Surg
2001;
33
: 679–687.
18. Mehta T, Venkata Subramaniam A, Chetter I, McCollum P. Assessing
the validity and responsiveness of disease-specific quality of life instru-
ments in intermittent claudication.
Eur J Vasc Endovasc Surg
2006;
31
: 46–52.
19. Remes L, Isoaho R, Vahlberg T, Viitanen M, Koskenvuo M, Rautava P.
Quality of life three years after major lower extremity amputation due
to peripheral arterial disease.
Aging Clin Exp Res
2010;
22
: 395–405.
20. Luther M. Surgical treatment of chronic critical leg ischaemia. A five-
year follow-up of survival, mobility, and treatment level.
Eur J Surg
1998;
164
: 35–43.
21. McDermott MM, Greenland P, Guralnik JM, Liu K, Criqui MH, Pearce
WH,
et al
. Depressive symptoms and lower extremity functioning in
men and women with peripheral arterial disease.
J Gen Intern Med
2003;
18
(6): 461–467.
22. D’Audiffret AC, Frisbee SJ, Stapleton PA, Goodwill AG, Isingrini
E, Frisbee JC. Depressive behavior and vascular dysfunction: a link
between clinical depression and vascular disease?
J Appl Physiol
2010;
108
(5): 1041–1051.
23. Cherr GS, Wang J, Zimmerman PM, Dosluoglu HHJ. Depression is
associated with worse patency and recurrent leg symptoms after lower
extremity revascularization.
Vasc Surg
2007;
45
(4): 744–750.
24. Dargon PT, Landry GJ. Buerger’s disease.
Ann Vasc Surg
2012;
26
(6):
871
–
880.
